INTERNATIONAL GRANTS
International Grants
Horizon 2020
|
Title |
Head of the project |
Duration |
|
Single-cell temporal tracking of epigenetic DNA marks (EpiTrack) ERC-2016-ADG: 742654 |
S. Klimašauskas |
2017–2023 |
|
Eat me microglia: lipid scrambling as a signal for synaptic pruning MSCA-IF-2015-EF: 705452 |
U. Neniškytė A. Alaburda |
2016–2021 |
|
SINGLY: Glycobiology of synaptic pruning in developing brain, Marie Skłodowska Curie Actions Individual Fellowship |
A. Parimisetty U. Neniškytė |
2020–2022 |
|
Title |
Lead scientist |
Duration |
|
Sonic drilling coupled with automated mineralogy and chemistry On-Line-On-Mine-Real-Time (SOLSA) SC5-11d-2015: 689868 |
S. Gražulis |
2016–2020 |
|
Directed EVOlution in DROPS (EVOdrops) MSCA-ITN-2018: 813786 |
L. Mažutis |
2018–2022 |
Baltic Research Program
|
Title |
Lead scientist |
Duration |
|
Novel high-performance polymers from lignocellulosic feedstock (EMP426) |
I. Matijošytė |
2020–2024 |
European Joint Program on Rare Diseases
|
Title |
Head of the project |
Duration |
|
Unveiling the role of glutamate in dopamine transporter deficiency syndrome (URGENT) |
J. Razumienė |
2020–2023 |
EuroNanoMed3 - European Innovative Research & Technological Development Projects in Nanomedicine
|
Title |
Lead scientist |
Duration |
|
A liquid corneal glue-filler as an alternative to transplantation in high-risk patient (LIQD-CORNEA) |
V. Bukelskienė |
2019–2022 |
Lithuanian-French Program Gilibert
|
Title |
Lead scientist |
Duration |
|
Characterization of antiplasmodial agent plasmodione and its metabolites (P-LZ-19-10) |
N. Čėnas |
2019–2020 |
|
New methods for modelling protein-protein and protein-ligand interactions (P-LZ-19-11) |
Č. Venclovas |
2019–2020 |
Lithuania-Japan Research Program
|
Title |
Lead scientist |
Duration |
|
Individual gamma frequency-based neurofeedback: development and implementation study (S-LJB-20-1) |
I. Griškova Bulanova |
2020–2022 |
Lithuanian-Latvian-Taiwanese Tripartite Cooperation Program
|
Title |
Head of the project |
Duration |
|
Brain-computer music interfacing for embodied musical interaction (P-LLT-19-12) |
I. Griškova-Bulanova |
2019–2021 |
|
Development of lead inhibitor of carbonic anhydrase IX as anticancer drug (S-LLT-20-2) |
D. Matulis |
2020–2022 |
Lithuania-Poland Cooperation Program Daina
|
Title |
Lead scientist |
Duration |
|
Long-distance electrical signalling systems in plants – adaptation to the change from water to terrestrial environment (P-LL-18-47) |
V. Kisnerienė |
2018–2021 |
|
Genomic insights into the mechanisms of drug resistance, virulence, and transmission of Mycobacterium tuberculosis strains from Lithuania and Poland |
P. Stakėnas |
2018–2021 |
|
CRISPR tools for the study of embryonic development in zebrafish (S-LL-18-7) |
G. Tamulaitis |
2018–2021 |
Other International Projects
|
Title |
Lead scientists |
Duration |
|
Cdk5 confers tumour resistance to adaptive immunity by PDL1 upregulation (St. Baldrick's Foundation grant) |
A. Petrošiūtė |
2020–2021 |
|
The processing of highly salient and biologically relevant emotional stimuli: gender differences and relationship to sex steroids. DAAD |
R. Grikšienė
|
2020 |
|
The investigation of the glycobiology of dissected glioblastoma human brain tissue. GlioGly. DAAD |
U. Kuliešiūtė
|
2020 |
|
Mycorrhizal partners of Diphasiastrum spp. - are fungi involved in a nutrient network. Mycorrhizal. DAAD |
R.Rimgailė-Voicik
|
2020 |
|
IBRO-PERC InEurope Short Stay Grants |
U. Kuliešiūtė |
2020–2021 |
|
IBRO Return Home Fellowship |
R. Guzulaitis |
2020–2022 |
|
European Space Agency (ESA). 5th call under the Plan for European Cooperating States (PECS) in Lithuania “Antimicrobial Photoinactivation Approach Based on Natural Agents for Control of Bacteria Biofilms in Spacecraft. Feasibility Study (LT5_1) |
L.Kalėdienė A.Gricajeva |
2020–2021 |
COST
|
Title |
Management Committee members |
Duration |
|
In vitro 3-D total cell guidance and fitness (CA16119) |
D. Baltriukienė V. Bukelskienė |
2016–2021 |
|
European Network of Multidisciplinary Research and Translation of Autophagy Knowledge (TRANSAUTOPHAGY) (CA15138) |
V. Borutinskaitė R. Navakauskienė |
2015–2020 |
|
European Research Network on Signal Transduction (ERNEST) (CA18133) |
R. Budvytytė M. Jankunec |
2020–2023 |
|
European Network for Problematic Usage of the Internet (CA16207) |
I. Griškova-Bulanova |
2017–2021 |
|
The neural architecture of consciousness (CA18106) |
I. Griškova-Bulanova |
2019–2023 |
|
Evaluation of antifungal activity of silver nanocomposites against various clinically relevant yeast and fungi. ECOST-STSM-Request-CA15114-45747 |
V. Kalcienė |
2020 |
|
European transdisciplinary networking platform for marine biotechnology (CA18238) |
I. Matijošytė R. Šiekštelė |
2019–2023 |
|
Between atom and cell: integrating molecular biophysics approaches for biology and healthcare (MOBIEU) (CA15126) |
D. Matulis A. Zubrienė |
2015–2020 |
|
International Network for Translating Research on Perinatal Derivatives into Therapeutic Approaches (CA17116) |
R. Navakauskienė J. Savickienė |
2018–2022 |
|
Delivery of antisense RNA therapeutics (CA17103) |
S.Serva, A.Konovalovas |
2018–2020 |
|
Personalized nutrition in aging society: redox control of major age-related diseases (CA16112) |
V. Smirnovas L. Baranauskienė |
2016–2021 |
|
New exploratory phase in research on East European cultures of dissent (CA16213) |
V. Vaitkevičius I. Kelpšienė |
2017–2021 |
|
Multi-target paradigm for innovative ligand identification in the drug discovery process (Mu TaLig) (CA15135) |
A. Zubrienė L. Baranauskienė |
2015–2020 |
NATIONAL PROJECTS 2020
National Projects
|
Individualized analysis of upper respiratory tract microbiome – a novel diagnostic and healthcare tool (YourAirwayMicrobiome) (No. 01.2.2-LMT-K-718-03-0079) |
J. Armalytė |
2020–2023 |
|
Development of virus-like particles-based vaccine against Acinetobacter baumannii (No. S-SEN-20-1) |
J. Armalytė |
2020–2021 |
|
Supramolecular recognition-based sensors for electro- detection of biomolecules (No. P-MIP-20-256) |
G. Bagdžiūnas |
2020–2022 |
|
Genetic and molecular analysis of the role of Tbx5a in heart regeneration (No. 09.3.3-LMT-K-712-17-0014) |
D. Balčiūnas |
2020–2023 |
|
Center for Genetic Modelling of Animals (No. 01.2.2-CPVA-K-703-03-0032) |
D. Baltriukienė |
2020–2023 |
|
Interactions of misfolded proteins and phospholipid membranes: possible key in neurodegeration (NeuroMisFolDe) (No. 09.3.3-LMT-K- 712-18-0003) |
R. Budvytytė |
2020–2022 |
|
Artificial urethra for the treatment of hypospadias and urethral strictures (No. 01.2.2-LMT-K-718-03-0087) |
V. Bukelskienė |
2020–2023 |
|
Targeting the microbiota-gut-brain axis in Alzheimer’s disease: the role of the endocannabinoid system (No. 01.2.2-LMT-K-718-02-0014) |
A. Burokas |
2019–2023 |
|
Biomarkers of the gut microbiota in autistic spectrum disorders (No. 01.2.2-LMT-K-718-03-0099) |
A. Burokas |
2020–2023 |
|
A healthy microbiota for a healthy brain ageing (No. P-SEN-20-35) |
A. Burokas |
2020–2021 |
|
Self-assembling phage proteins for targeted nanomedicine (No. P-SEN-20-34) |
V. Časaitė |
2020–2021 |
|
Redox chemistry, biochemistry and cytotoxicity of aromatic nitrocompounds and N-oxides: new insights (No. DOTSUT-34/09.33-LMT-K712-01-0058) |
N. Čėnas |
2018–2021 |
|
Screening for new methods for treatment of neurodegenerative disorders (No. 01.2.2-LMT-K-718-03-0021) |
E. Čiplys |
2020–2023 |
|
Biocatalytic systems for conversion of non-starch poli- and oligosaccharides (No. 01.2.2-LMT-K-718-01-0019) |
M. Dagys |
2018–2022 |
|
Development of biosensor research and engineering competence and technology transfer centre (BIOSENSE) (No. 01.2.2-CPVA-K-703-03-0010) |
M. Dagys |
2020–2023 |
|
Investigation of K.Lactis mutations conferring enhanced secretion phenotype and generation of yeast strains for supersecretion of recombinant proteins (No. S-MIP-17-88) |
A. Gedvilaitė |
2017–2020 |
|
Determinants of quality of life in Lithuanian students: problematic usage of the Internet and neuropsychological profile (No. S-GEV-20-5). |
I. Griškova Bulanova |
2020–2022 |
|
Modern technologies to resolve a complex structure of tumor (No. S-MIP-17/54) |
S. Jarmalaitė |
2017–2020 |
|
Molecular mechanisms of adaptation of low-temperature phages to the mesophilic host (No. P-MIP-19-259 ) |
L. Kalinienė |
2019–2022 |
|
Designing of the patient-specific, heterogeneous lung cancer cell ex vivo model system for drug efficiency prediction in personalized oncotherapy (No. 01.2.2-LMT-K-718-01-0072) |
A. Kalvelyte |
2018–2022 |
|
Hypoxia as cell stress in mRNA diversity and aging (No. S-SEN-20-17) |
A. Kanopka |
2020–2021 |
|
Handles for selective manipulations of biosynthetic proteins (No. S-MIP-17-57) |
S. Klimašauskas |
2017–2020 |
|
Single molecule TOP-Seq – an innovative technological platform for early non-invasive diagnostics of cancer and other epigenetic disorders (No. 09.3.3-LMT-K-712-01-0041) |
E. Kriukienė |
2018–2022 |
|
A technology for single-cell analysis of genomic DNA modification. Neuroblastoma epigenetic heterogeneity (No. S-MIP-17-58) |
E. Kriukienė |
2017–2020 |
|
Analysis of immunological, genetic, epigenetic factors in the etiopathogenesis of autoimmune arthritis (No. S-MIP-17-12) |
R. Kubiliūtė |
2017–2020 |
|
The impact of viral antigens on immune cells in the context of inflammaging (No. S-SEN-20-11) |
I. Kučinskaitė-Kodzė |
2020–2021 |
|
Discovery of novel bioactive microbial compounds in the unique environment: an investigation of the diversity, prevalence and expression (No. MIP-17-21) |
N. Kuisienė |
2017–2022 |
|
The influence of intensive fish farming on aquatic microbiome and resistome (No. S-SIT-20-6). |
E. Lastauskienė |
2020–2021 |
|
Surface nano-structures for mechanistic studies of DNA - protein interaction at the single-molecule level (No. S-MIP-17-59) |
E. Manakova |
2017–2020 |
|
A system of restful web services for protein remote homology search in real time and protein modelling (No. 01.2.2-LMT-K-718-01-0028) |
M. Margelevičius |
2018–2022 |
|
Development of visualization systems for tumor and metastases detection in cancer diagnostics and optically-guided surgery using CA IX biomarker (No. S-SEN-20-10) |
J. Matulienė |
2020–2021 |
|
The mechanism of inhibitor recognition by carbonic anhydrases - towards anticancer therapy (No. S-MIP-17-87) |
D. Matulis |
2017–2020 |
|
Design of pharmaceutical compounds for the treatment of cancer and neurodegenerative diseases (No. 01.2.2.-CPVA-K-703-03-0006) |
D. Matulis |
2020–2023 |
|
Design of compounds inhibiting BACE1 enzymatic activity and Aβ peptide aggregation for the treatment of Alzheimer’s disease (No. 01.2.2-LMT-K-718-03-0003) |
D. Matulis |
2020–2023 |
|
Microfluidic technologies for single-cell geno- and phenotyping research (No. 09.3.3-LMT-K-712-01-0056) |
L. Mažutis |
2018–2021 |
|
Establishment of single-cell transcriptomics/genomics research parallel-laboratory (No. 01.2.2-LMT-K-718-04-0002) |
L. Mažutis |
2020–2023 |
|
Chemical annotation in the Crystallography Open Database (COD) (No. S-MIP-20-21) |
A. Merkys |
2020–2022 |
|
Prodrug-Enzyme selection system (No. 31V-59/(1.78)SU-1687) |
R. Meškys |
2019–2020 |
|
Centre for engineering of the next-generation enzymes (TVIRTAS) (No. 01.2.2-CPVA-K-703-03-0023) |
R. Meškys |
2020–2023 |
|
Selective enzymatic system for prodrug activation (No. 01.2.2-LMT-K-718-03-0082) |
R. Meškys |
2020–2023 |
|
Development of innovative targeted therapies and prognostic tools for chemotherapy-resistant acute myeloid leukemia (No. P-SEN-20-14) |
R. Navakauskienė |
2020–2021 |
|
The role of epigenetic oscillations in predicting biological age (No. S- MIP-19-192) |
A. Petronis |
2019–2022 |
|
Identifying chronoepigenetic markers in schizophrenia (No. 09.3.3-LMT-K-712-17-0008) |
A. Petronis |
2020–2023 |
|
Next generation epigenetic markers for accelerated ageing in colorectal cancer (No. S-SEN-20-19) |
A. Petronis |
2020–2021 |
|
The prevalence and distribution of virulence factors among subgroups of vaginal bacteria Gardnerella Vaginalis (No. S-MIP-17-49) |
M. Plečkaitytė |
2017–2020 |
|
Studies on the virulence potential of meningococcal isolates: implications for an improved molecular diagnostics of invasive meningococcal disease (No. 01.2.2-LMT-K-718-03-0036) |
M. Plečkaitytė |
2020–2023 |
|
Biosensor platform for fast, cheap and accurate quantification of amino acids in patients undergoing renal replacement therapy (No. 01.2.2-LMT-K-718-03-0005) |
D. Ratautas |
2020–2023 |
|
Development of non-invasive method platform for early diagnostics and prognosis of acute pancreatitis (No. 01.2.2-LMT-K-718-01-0025) |
J. Razumienė |
2018–2022 |
|
Biodiversity and ecological peculiarities of aphid species (Hemiptera: Adelgidae, Lachnidae) inhabiting coniferous host plants in Central Europe (No. P-MIP-17-365) |
R. Rakauskas |
2017–2020 |
|
Adaptation mechanism in Class 2 CRISPR-Cas systems (No. S-MIP-19-305) |
G. Sasnauskas |
2019–2022 |
|
Cross-interactions in amyloid fibril formation: from mechanisms to inhibition (No. S-SEN-20-3) |
V. Smirnovas |
2020–2021 |
|
The role of atmospheric nitrogen fixation in the largest eutrophicated European lagoon (No. P-MIP-17-126) |
R. Stanislauskienė |
2017–2020 |
|
Enzyme toolkit for the synthesis of fucosylated oligosaccharides (No. 01.2.2-LMT-K-718-03-0045) |
J. Stankevičiūtė |
2020–2023 |
|
Molecular mechanisms of new bacterial antiviral systems (No. 09.3.3-LMT-K-712-01-0126) |
V. Šikšnys |
2018–2022 |
|
Diversity and distribution of viruses infecting sulphur metabolising bacteria (No. P-MIP-20-329) |
E. Šimoliūnas |
2020–2022 |
|
Search of Anti-CRISPR proteins and research of their action (No. S-MIP-20-39) |
T. Šinkūnas |
2020–2022 |
|
Research and practical applications of a type I-F CRISPR-Cas system (No. S-MIP-17-47) |
G. Tamulaitienė |
2017–2020 |
|
Studies of genome editing tools at the single-molecule level (No. S-MIP-20-55) |
M. Tutkus |
2020–2022 |
|
Quantitative detection of phospholipid membrane damage by pore-forming toxin (No. P-MIP-19-394) |
G. Valinčius |
2019–2020 |
|
Development of novel proteomics-based drug selection approach for pancreatic cancer individualized therapy (No. P-SEN-20-39) |
M. Valius |
2020–2021 |
|
Computational study of evolutionary relationships, genomic distribution, structural and functional properties of DNA polymerases (No. 09.3.3-LMT-K-712-01-0080) |
Č. Venclovas |
2018–2022 |
|
Analysis and prediction of structural features of proteins and protein complexes using interatomic contact areas and evolutionary information (No. S-MIP-17-60) |
Č. Venclovas |
2017–2020 |
|
Analysis of 5`-capped RNAs and its modulating proteins in E. coli and probiotic lactic acid bacteria (No. S- MIP-19-217) |
G. Vilkaitis |
2019–2022 |
|
Sequencing centre of DNA double stranded breaks (No. 01.2.2-CPVA-K-703-02-0010). |
M. Zaremba |
2018–2023 |
|
Structural and functional studies of prokaryotic Argonaute proteins (No. S-MIP-17-61) |
M. Zaremba |
2017–2020 |
|
Structural and functional studies of split prokaryotic Argonaute proteins (No. S-MIP-20-37) |
M. Zaremba |
2020–2022 |
|
Development of labelled antibodies for in vitro diagnosis of allergies (No. TPP-03-031) |
A. Žvirblienė |
2019–2020 |
|
Novel affinity binders for immunodetection of antimicrobial resistance (No. 01.2.2.-MITA-K-702-05-0003) |
A. Žvirblienė |
2020–2023 |
|
New technologies for development of recombinant allergens (No. 01.2.2-LMT-K-718-01-0008) |
G. Žvirblis |
2018–2022 |
NATIONAL PROJECTS 2019
|
Targeting the microbiota-gut-brain axis in Alzheimer’s disease: the role of the endocannabinoid system (No. 01.2.2-LMT-K-718-02-0014) |
A. Burokas |
2019–2023 |
|
|
Redox chemistry, biochemistry and cytotoxicity of aromatic nitrocompounds and N-oxides: new insighths (No. DOTSUT-34/09.33-LMT-K712-01-0058) |
N. Čėnas |
2018–2021 |
|
|
Biocatalytic systems for conversion of non-starch poli- and oligosaccharides (No. 01.2.2-LMT-K-718-01-0019) |
M. Dagys |
2018–2022 |
|
|
Investigation of K.Lactis Mutations Conferring Enhanced Secretion Phenotype and Generation of Yeast Strains for Supersecretion of Recombinant Proteins (No. S-MIP-17-88) |
A. Gedvilaitė |
2017–2020 |
|
|
Modern technologies to resolve a complex structure of tumor (No. S-MIP-17/54) |
S. Jarmalaitė |
2017–2020 |
|
|
Molecular mechanisms of adaptation of low-temperature phages to the mesophilic host (No. P-MIP-19-259 ) |
L. Kalinienė |
2019–2022 |
|
|
Designing of the patient-specific, heterogeneous lung cancer cell ex vivo model system for drug efficiency prediction in personalized oncotherapy (No. 01.2.2-LMT-K-718-01-0072) |
A. Kalvelyte |
2018–2022 |
|
|
Handles for Selective Manipulations of Biosynthetic Proteins (No. S-MIP-17-57) |
S. Klimašauskas |
2017–2020 |
|
|
Single Molecule TOP-Seq – an Innovative Technological Platorm for Early Non-Invasive Diagnostics of Cancer and Other Epigenetic Disorders (No. 09.3.3-LMT-K-712-01-0041) |
E. Kriukienė |
2018–2022 |
|
|
A Technology for Single-Cell Analysis of Genomic DNA Modification. Neuroblastoma Epigenetic Heterogeneity (No. S-MIP-17-58) |
E. Kriukienė |
2017–2020 |
|
|
Analysis of immunological, genetic, epigenetic factors in the etiopathogenesis of autoimmune arthritis (No. S-MIP-17-12) |
R. Kubiliūtė |
2017–2020 |
|
|
The search for new bacterial collagen-like proteins, their heterologous expression and characterization (No. 09.3.3-LMT-K-712-02-0092) |
N. Kuisienė |
2017–2019 |
|
|
Discovery of novel bioactive microbial compounds in the unique environment: an investigation of the diversity, prevalence and expression (No. MIP-17-21) |
N. Kuisienė |
2017–2022 |
|
|
Surface Nano-Structures for Mechanistic Studies of DNA - Protein Interaction at the Single-Molecule Level (No. S-MIP-17-59) |
E. Manakova |
2017–2020 |
|
|
A System of Restful Web Services for Protein Remote Homology Search in Real Time and Protein Modeling (No. 01.2.2-LMT-K-718-01-0028) |
M. Margelevičius |
2018–2022 |
|
|
The Mechanism of Inhibitor Recognition by Carbonic Anhydrases - Towards Anticancer Therapy (No. S-MIP-17-87) |
D. Matulis |
2017–2020 |
|
|
Microfluidic Technologies for Single-Cell Geno- and Fenotyping Research (No. 09.3.3-LMT-K-712-01-0056) |
L. Mažutis |
2018–2021 |
|
|
Prodrug-Enzyme selection system (No. 31V-59/(1.78)SU-1687) |
R. Meškys |
2019–2020 |
|
|
The role of epigenetic oscillations in predicting biological age (No. S- MIP-19-192) |
A. Petronis |
2019–2022 |
|
|
The Prevalence and Distribution of Virulence Factors among Subgroups of Vaginal Bacteria Gardnerella Vaginalis (No. S-MIP-17-49) |
M. Plečkaitytė |
2017–2020 |
|
|
Development of Non-invasive method platform for early diagnostics and prognosis of acute pancreatitis (No. 01.2.2-LMT-K-718-01-0025) |
J. Razumienė |
2018 – 2022 |
|
|
Biodiversity and Ecological Pecularities of Aphid Species (Hemiptera: Adelgidae, Lachnidae) Inhabiting Coniferous Host Plants In Central Europe (No. P-MIP-17-365) |
R. Rakauskas |
2017–2020 |
|
|
Adaptation mechanism in Class 2 CRISPR-Cas systems (No. S-MIP-19-305) |
G. Sasnauskas |
2019–2022 |
|
|
The role of atmospheric nitrogen fixation in the largest eutroficated European lagoon (No. P-MIP-17-126) |
R. Stanislauskienė |
2017–2020 |
|
|
Molecular Mechanisms of New Bacterial Antiviral Systems (No. 09.3.3-LMT-K-712-01-0126) |
V. Šikšnys |
2018–2022 |
|
|
Bacteriophage control of nitrogen cycling in cyanobacteria: from cells to community (No. P-MIP-17-6) |
E. Šimoliūnas |
2017–2019 |
|
|
Research and Practical Applications of a Type I-F CRISPR-Cas System (No. S-MIP-17-47) |
G. Tamulaitienė |
2017–2020 |
|
|
Quantitative detection of phospholipid membrane damage by pore-forming toxin (No. P-MIP-19-394) |
G. Valinčius |
2019–2020 |
|
|
Computational Study of Evolutionary Relationships, Genomic Distribution, Structural and Functional Properties of DNA Polymerases (No. 09.3.3-LMT-K-712-01-0080) |
Č. Venclovas |
2018–2022 |
|
|
Analysis and Prediction of Structural Features of Proteins and Protein Complexes Using Interatomic Contact Areas and Evolutionary Information (No. S-MIP-17-60) |
Č. Venclovas |
2017–2020 |
|
|
Analysis of 5`-capped RNAs and its modulating proteins in E. coli and probiotic lactic acid bacteria (No. S- MIP-19-217) |
G. Vilkaitis |
2019–2022 |
|
|
Sequencing Center of DNA Double Stranded Breaks (No. 01.2.2-CPVA-K-703-02-0010). |
M. Zaremba |
2018–2023 |
|
|
Structural and Functional Studies of Prokaryotic Argonaute Proteins (No. S-MIP-17-61) |
M. Zaremba |
2017–2020 |
|
|
Development of labeled antibodies for in vitro diagnosis of allergies (No. TPP-03-031) |
A. Žvirblienė |
2019-2020 |
|
|
New technologies for development of recombinant allergens (No. 01.2.2-LMT-K-718-01-0008) |
G. Žvirblis |
2018–2022 |